Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 3

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants

Total article views   HTML views PDF downloads Totals
7,745 Dovepress* 7,745+ 2,125 9,870
Totals 7,745 2,125 9,870
*Since 12 September 2008
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on Google Scholar